The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating tumor genomics and FES-PET in estrogen receptor–positive (ER+) breast cancer (BC).
 
Elena Michaels
No Relationships to Disclose
 
Eric Strand
No Relationships to Disclose
 
Chantal Ferguson
Patents, Royalties, Other Intellectual Property - Atalanta Therapeutics/UMass Chan Medical School
 
Alifya Lokhandwala
No Relationships to Disclose
 
Beverly Moy
No Relationships to Disclose
 
Steven Isakoff
Employment - Merus NV (I)
Stock and Other Ownership Interests - Merus NV (I)
Consulting or Advisory Role - AstraZeneca; BioNTech; Veracyte
Research Funding - Abbvie; AstraZeneca/MedImmune; Genentech; Merck; OncoPep
 
Rachel Jimenez
Consulting or Advisory Role - Alexion Pharmaceuticals
 
Samantha Harrington
Consulting or Advisory Role - GE Healthcare
 
Seth Wander
Consulting or Advisory Role - Arvinas; AstraZeneca; Biovica; Foundation Medicine; Genentech/Roche; Gilead Sciences; Hologic; Lilly; Novartis; Pfizer; Puma Biotechnology; Regor Therapeutics; Stemline Therapeutics; Veracyte
Speakers' Bureau - 2nd.MD; Guardant Health; Lilly
Research Funding - Arvinas; Genentech; Lilly; Nuvation Bio; Pfizer; Puma Biotechnology; Regor Therapeutics; Sermonix Pharmaceuticals; Stemline Therapeutics